Clinical Trials Logo

Sleep Wake Disorders clinical trials

View clinical trials related to Sleep Wake Disorders.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06399952 Recruiting - Sleep Disorder Clinical Trials

Baker Gordon Syndrome Natural History Study

BAGOS
Start date: April 30, 2024
Phase:
Study type: Observational

The goal of this study is to conduct a prospective, longitudinal assessment of the natural clinical progression of children and adults with Synaptotagmin1-Associated Neurodevelopmental Disorder also known as Baker Gordon Syndrome (BAGOS). This will be performed by acquiring baseline measurements and developing effective outcome measures and diagnostic tools for the disorder, to prepare the healthcare system for future clinical trials.

NCT ID: NCT06381479 Recruiting - Stress Clinical Trials

Exploring the Effects of Probiotics on Workplace Related Stress Symptoms

Start date: April 19, 2024
Phase: N/A
Study type: Interventional

There is still a lack of research to explore the interaction between high-pressure workers and probiotics to improve the intestinal microbiota, sleep, inflammation and anti-oxidation. A total of 120 subjects are expected to be recruited and divided into two groups of 60 subjects, receiving probiotics or placebo, and completing a 8-week trial period.

NCT ID: NCT06373445 Recruiting - Clinical trials for Neuromodulation and Sleep Disorders

Interventional Neuromodulation in Fibromyalgia

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

This study was conducted on 40 eligible fibromyalgia patients with sleep disorders. They were randomized to have 20 sessions of active or sham rTMS (1 Hz, 120% of resting motor threshold with total 1200 pules /session) over the right dorsolateral prefrontal area (DLPFC) for 5 sessions/week for 4 weeks. All participants were subjected to baseline evaluation with Fibromyalgia Impact Questionnaire, polysomnography, sleep quality and sleep characteristics assessment using the Pittsburgh Sleep Quality Index and The Medical Outcomes Study Sleep Scale respectively.FM patients were reevaluated at 1, 3 months after the end of rTMS sessions.

NCT ID: NCT06367400 Recruiting - Clinical trials for Obstructive Sleep Apnea

Validation of Pediatric Sleep Questionnaire on a Swedish Cohort

Start date: March 1, 2024
Phase:
Study type: Observational

This study is aimed to validate the questionnaire called Pediatric Sleep Questionnaire on a Swedish cohort of children from 18 months to 15 years old with obstructive sleep disordered breathing.

NCT ID: NCT06359808 Recruiting - Colitis, Ulcerative Clinical Trials

Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis

Start date: April 1, 2024
Phase:
Study type: Observational

Ulcerative colitis(UC) is one of the two main forms of inflammatory bowel disease(IBD), which seriously affects the quality of life of patients. Previous studies have demonstrated that more than 60% of IBD patients have sleep disorders, which is emerging as an important risk factor for disease recurrence and poor prognosis. However, the mechanisms by which sleep disorders regulates the occurrence and development of IBD remain undefined. This study aims to explore the clinical characteristics of ulcerative colitis patients with sleep disorders based on the microbiota-gut-brain axis, to analyze the effects of sleep disorders on autonomic nervous function, gut microbiota, and metabolites in UC patients.

NCT ID: NCT06347744 Recruiting - Sleep Clinical Trials

Radicle Rest 24: A Study of Health and Wellness Products on Sleep and Related Health Outcomes

Start date: May 23, 2024
Phase: N/A
Study type: Interventional

A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on sleep and related health outcomes.

NCT ID: NCT06342817 Recruiting - Sleep Disorder Clinical Trials

Effects of Meditation on Sleep Quality of Medical Students

Start date: October 18, 2023
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the effect of an 8-week online mindfulness-based meditation program on quality sleep status of undergraduate students medicine in the city of Passo Fundo/RS and Chapecó/SC In addition to sleep quality, secondary outcomes such as mindfulness, symptoms of depression, stress, anxiety and burnout will also be assessed

NCT ID: NCT06341374 Recruiting - Clinical trials for SARS CoV 2 Infection

Impact of Sleep Disorders on Innate Immunity in COVID-19 Patients

Start date: November 6, 2023
Phase:
Study type: Observational [Patient Registry]

Sleep is an important modulator of the immune response, whereby sleep disturbances (ie, poor sleep quality, insufficient sleep and/or primary sleep disorder, obstructive sleep apnea (OSA)) contribute to inflammatory disease risk and dysregulation of immune response in front of infectious agents. The objective of this study is to evaluate the impact of undiagnosed and non-treated sleep disorders on innate immunity in a cohort of COVID-19 patients and the role of trained immunity induced by influenza vaccination in the innate immune response.

NCT ID: NCT06334640 Recruiting - Sleep Disorder Clinical Trials

Sleeping Quality and Chronic Ocular Diseases

SONNO-OCU
Start date: October 17, 2023
Phase:
Study type: Observational

To assess the impact of sleep quality on chronic eyes diseases

NCT ID: NCT06312956 Recruiting - Clinical trials for Obstructive Sleep Apnea

Multidimensional Evaluation of Patients' Affected by Obstructive Apnea Syndrome (OSAS) Before and After Ventilotherapy

MULTI-OSAS
Start date: February 29, 2024
Phase:
Study type: Observational

This observational study aims to evaluate multiple dimensions of health in patients with Obstructive Sleep Apnea Syndrome (OSAS), before and after three weeks of ventilotherapy. Specifically, the study aims to identify pre- vs post-treatment differences in the following domains: - cognitive performance - blood expression of biomarkers related to neurodegeneration - psychosocial wellbeing Thus, patients will complete the following evaluations before (T0) and after (T1) ventilotherapy: - neuropsychological standard assessment - blood sampling - psychosocial self-reported questionnaires